Daniel Keith – Dermatology Registrar

Slides:



Advertisements
Similar presentations
Basal Cell Nevus Syndrome Daniel Berg M.D., FRCPC Director, Dermatologic Surgery University of Washington.
Advertisements

NonMelanoma Skin Cancer Dr David Burdon-Jones Consultant Dermatologist Dorset County Hospital Foundation Trust Interactive.
Dermatology Clinical Assessment and Treatment Service: NW Hertfordshire (St Albans, Harpenden and Hertsmere) Dr. Simon Dawe Consultant Dermatologist.
Management of Vulval Cancer Services in South West England Jenny Weeks J Verne L Hirschowitz, V Udaysanker, AD Falconer on behalf SWCIS Gynaecology Tumour.
Guidance on Cancer Services Improving Outcomes for People with Skin Tumours including Melanoma NICE Stateholder Consultation version July 2005.
Basal Cell Carcinoma Presented by: Bill V. Way, D.O. AOCD Board Certified Dermatologist Residency in US Army at Walter Reed Consultant for Charlton Methodist.
Skin Cancer Carlos Garcia MD Dermatology at OUHSC No conflicts of interest to disclose.
The National Mastectomy and Breast Reconstruction Audit Key findings of the Third Annual Report Slides produced by the MBR Project Team. © The National.
Dermatology Services for Patients with Vulval Disease
Skin Cancer Network Group Audit of Clinical Performance Indicators: Data quality and treatment quality Anna Murray BSc Cancer Information Analyst
Katie Ludwig FY1.   50, 285 New cases of breast cancer  11, 716 deaths  78% - 10 year survival rates  27% preventable cases  Source:
DR. OLGA WATKINS November Outline Of Presentation Common Skin Lesions, Benign And Malignant Assessment Of Pigmented Lesion Points to take home.
BCCs & GPs Dr Victoria Brown Consultant Dermatologist West Hertfordshire Hospitals NHS Trust.
Skin Cancer by Yousuf Asfour.
Stereotactic Ablative Body Radiotherapy for Non small cell lung cancer
Dr Joanna Fawcett Dr Jonathan Wordsworth Dr David de Berker.
The management of low-risk basal cell carcinomas in the community Implementing NICE guidance in general practice May 2010 NICE guidance on cancer services.
Two-week wait referrals for malignant melanoma: A clinical audit carried out across four UK Cancer Networks South West Cancer Intelligence Service
British Association of Dermatologists National Clinical Audit Programme 2014: NMSC excision.
Photodynamic Therapy for Pre-cancerous lesions of the skin Alan Milligan Clinical Nurse Specialist for Non-Melanoma Skin Cancers.
Skin Cancer Assessment And Treatment Centre Our Specialist Dermatologists in Melbourne are experts in the diagnosis of Different Skin Cancers.
National Bowel Cancer Audit
“Malignant skin tumors”
Mohs micrographic surgery SWAG network service Update May 2016
SWAG SSG Sarcoma Meeting
Non-melanoma skin cancer reconstruction of the head and neck region at Northampton General Hospital: a case series. Iqbal U1, Kapasi F2 Ameerally P3 1.
Oesophago–Gastric Cancer
Tips for Inserting Graphs or Images Tips for Title/Headers Bar Color
SWAG SSG Skin Cancer Meeting
Advanced Marjolin`s ulcer of the scalp
Skin Cancer Diagnoses and Treatments.
SWAG SSG Colorectal Cancer Meeting
Brain imaging prior to lung cancer resection
Analysis of Incompletely Excised BCCs (4.68%)
European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: Results of the treatment of skin cancer  Giulia Bertino, Gregor Sersa,
P. Surda, S. Hampal, H. Fowler, R. Goggins
Audit of Results of Lid Tumour Excision
Emerging Trends in the Treatment of Advanced Basal Cell Carcinoma
F.M. Lewis, F.M. Tatnall, S.S. Velangi, C. B. Bunker,
SKIN CANCER.
Basal Cell Carcinoma.
SWAG SSG Sarcoma Cancer Meeting
Pathway for patients with suspected Skin Cancer
NICE-BAD clinical audit on psoriasis
Hannah Marder Cancer Manager UH Bristol
The BAHNO Head & Neck Cancer Surveillance Audit 2018
‘Improving Outcomes for people with skin tumours, including Melanoma’
National Oesophago-Gastric Cancer Audit 2018 Annual Report: Slide set
SWAG SSG Head and Neck Cancer Meeting
The BAHNO Head & Neck Cancer Surveillance Audit 2018
SWAG SSG Sarcoma Meeting
Skin Cancer NICE Quality Standard
Patient Education and Support following treatment for Skin Cancer
Safety of community-based minor surgery performed by GPs: an audit in different settings by Jonathan Botting, Ana Correa, James Duffy, Simon Jones, and.
Skin cancer primary tumour (pT) staging changes from Jan 2018
SWAG SSG Lung Cancer Meeting
Tumor Recurrence 5 Years after Treatment of Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma  Mary-Margaret Chren, Eleni Linos, Jeanette S.
SWAG Cancer Network Meeting 23 May 2018
BAD-BSDS-RCPath national audit on non-melanoma skin cancer excision
Reconstruction of nasal defects using modified composite grafts
Somerset, Wiltshire, Avon and Gloucestershire Cancer Services
R.W. Griffiths, S.K. Suvarna, J. Stone 
NCL Teledermatology Service Lead by:
F.M. Lewis, F.M. Tatnall, S.S. Velangi, C. B. Bunker,
Surgical re-excision versus observation for histologically dysplastic nevi: a systematic review of associated clinical outcomes K.T. Vuong1, J. Walker2,
Squamous cell carcinoma pathway update
The utility of optical coherence tomography for diagnosis of basal cell carcinoma: a quantitative review N. Reddy and B.T. Nguyen Department of Dermatology,
SCC MDT Service Evaluation
Somerset, Wiltshire, Avon & Gloucestershire Cancer Alliance
Presentation transcript:

Somerset, Wiltshire, Avon & Gloucestershire (SWAG) Non-Melanoma Skin Cancer Excision Audit 2016 Daniel Keith – Dermatology Registrar David de Berker – Consultant Dermatologist daniel.keith@nhs.net

Background We are collecting data for our personal records, local audit and for submission to the national BAD audit. National audit only covers dermatologists Other work missed, e.g. CNS, plastics, max facs. There is a need for network/regional audit.

Why else collect this data? Being able to access data about your doctor is becoming the norm. Many surgical consultants now have their performance published for patients to browse. This is the future!

Method Submissions invited from those treating skin cancer in our regions. BAD National NMSC Excision Audit data collection tool distributed. 10 BCCs 5 SCCs Consecutive excisions Prospective if possible Submissions accepted from anyone operating on skin cancer in the region. Analyses to mirror the national audit for comparison Complete excision of a BCC or SCC is adequate treatment and completeness of excision is a NICE standard.

15 respondents from 5 trusts. Somerset, Bristol and Gloucestershire 223 cases

36.9% data collected prospectively (compared to 44.8% nationally.

207 cases with usable data for site. Distribution mirrors national data More noses 58.5% Head and Neck (58.3% national)

67.1% of reported work was BCC As expected given the way data was requested.

BCC and SCC most common diagnoses. MM a rare missed diagnosis. Mirrors national picture.

BCC Clinical specificity 95.3% Suspected BCC confirmed on histology [95.8%] SCC Clinical specificity 86.3% Suspected SCC confirmed on histology [80.4%]

Mean size = 11.03mm (SD 5.71) (National 11.36) Largest tumour 34mm

The majority of tumours are cut out with adequate margins measured on histology as 1-5mm lateral and deep

Re-excisions 9 Re-excisions v 214 Primary Excisions 1 Complication in each group Within 10mm of a previous scar? No SCCs 6 BCCs, 5 with info on site - 2 limbs, 1 trunk, 1 nose, 1 cheek

Completeness of Excision 100% Lesions excised clear of the deep margins 98.2% Lesions excised clear of the lateral margins [National 98.2% deep / 99.9% lateral / 99.3% any (2014)] 91.9% Lesions excised clear > 1mm from the deep margin 95.1% Lesions excised clear > 1mm from the lateral margin 89.2% Lesions excised clear > 1mm from any margin Incompletely excised lesions. N=4 2 x BCC 1 x SCC 1 x MM

Diagnostic accuracy high (95.3% BCC / 86.3% SCC) Key findings Diagnostic accuracy high (95.3% BCC / 86.3% SCC) BCC within limits expected from other literature SCC higher than reported in literature [1] Potential for bias with retrospective data and the way cases were requested Mean tumour size 11.03mm Follows the national average Defect sizes of 19mm with 4mm clinical margins (H+N) Complications few but likely to be underestimated Completeness of excision similar to published and guidelines Clinical margins of 4-5mm should provide > 95% clearance rates. [2] 1. Ahnlide, Ingela, and Mats BjELLERUP. "Accuracy of clinical skin tumour diagnosis in a dermatological setting." Acta dermato-venereologica 93.3 (2013): 305-308. 2. Telfer, N. R., G. B. Colver, and P. W. Bowers. "Guidelines for the management of basal cell carcinoma." British Journal of Dermatology 141 (1999): 415-423.

Thank you daniel.keith@nhs.net